The Harbin Institute of Veterinary Research is successfully testing a vaccine against African swine fever. The Institute is a member of the China Academy of Agricultural Sciences (CAAS). The first test results were published this week.
Between April and June, clinical trials of the vaccine were carried out at three base enterprises located in Heilongjiang, Henan, and the Xinjiang Uygur Autonomous Region. More than 3,000 piglets received a vaccine from African swine fever. The development of vaccinated pigs takes place without visible problems and adverse effects. In addition, there were no pathological changes in the anatomy of experimental pigs. There were also no differences between the vaccinated group and the control group. The overall mortality rate decreased by 1%. Vaccinated piglets are not affected by African swine fever and are not carriers of the ASF virus. Chinese researchers do not intend to stop and plan to continue testing the effectiveness of the vaccine.